Are Scientists Really Dull?
Bruce Charlton, a professor of theoretical medicine at the University of Buckingham and Editor in Chief of the journal Medical Hypotheses recently published in Oxford magazine and his blog a provocative and controversial article entitled “Why Scientists Are So Dull”
The article, which caused a firestorm in the UK was crafted to get the scientific establishment to rethink its parochial approach to scientific training and career development for young scientists. Because of the blunt nature and in-your-face tone of the article, Dr. Charlton may have alienated some would-be supporters who unfortunately failed to see the intended humor and call-to-action of the article. Unfortunately, in my experience, the public perception of scientists is consistent with Dr. Charlton’s claim—that, we as a group, are dull.
Throughout my career, I have routinely been asked by non-scientists (after meeting them in social situations) “You’re not really a scientist—are you?” Invariably, they say something like “You are too funny and too much of a character to really be a scientist.”
I know that stereotyping is inherently dangerous and wrong, but stereotypes usually originate from commonly observed, shared characteristics (traits) exhibited by members of a particular group of people. That said, maybe it is time for us to let the lay public know that not all scientists are dull, “eggheads” types and that many of us are very insightful, creative people. In my opinion, the only way for us to lose the ‘dull’ moniker is to publicly promote the importance and creative aspects of science whenever we can. To that end, it is time for us to log off of our computers, leave our laboratories and let the world know that—contrary to public opinion—we aren’t DULL people!!!!
Until next time…
Good Luck and Good Job Hunting!!!!!!!
.jpg)
For those of you who want an answer to this age old question, 
.jpg)
I first thought about starting a social network for life sciences professionals about a year ago after joined I Facebook and LinkedIn and then learned about SciLink, one of the first social networks for scientists. Apparently, others had the same idea and today, there are currently, by my reckoning, no fewer than 20 social networks for scientists—each promoting a unique approach to networking for scientists.
m another one of Grace Abrams’ grifting victims. Apparently, this individual purchased a sick puppy from Ms. Abrams several months ago which at one year old developed some problems that likely resulted from congenital defects due to inbreeding. This person told me that a friend of hers also purchased a ‘Havanese” from Ms. Abrams which they suspect really isn’t a Havanese (despite ‘papers’ that indicate that it is). As you may recall, we also received suspect pedigree papers for the dogs that we purchased from Ms. Abrams (.jpg)
The other day I was chatting with .jpg)
ring people advice and tips on how to hold on to their current jobs. In my opinion, most of these posts didn’t offer any new or insight tips on this topics. Instead most of the suggestions were obvious and rather pedestrian. For example, be pleasant to your boss, show up on time, don’t leave before the official work day ends, volunteer to take on new projects yada, yada, yada..jpg)
I want to let my readers know that a beta-version of .jpg)
.jpg)
A Food and Drug Administration (FDA) advisory panel Thursday rejected a proposed antibiotic by Arpida Ltd. (ARPN.EB) to treat serious skin infections, a Food and Drug Administration spokeswoman said. The rejection was expected because results from Phase III clinical trials showed that patients taking iclaprim (a trimethoprim-like antibiotic) had lower cure rates than Pfizer's 
Astra Zeneca announced today that it would cut 1400 jobs and close several manufacturing facilities worldwide. .jpg)
The 
ost cases, everybody in the office, laboratory etc knows who these people are but are ill-equipped to effectively minimize the damage that they may cause. I highly recommend
Researchers at the 
An article in today’s New York Times.jpg)
ou all know by now, American pharmaceutical companies have been intermittently laying off thousands of employees for the past two years or so. Many of the employees who have lost their jobs are R& D scientists, marketing personnel and sales representatives. This seemingly makes sense—because fewer drugs are being discovered and brought to market, fewer people are required to market and sell them. That said, isn’t discovering new drugs the currency and lifeblood of the pharmaceutical industry? How do these companies plan to stay in business if they continue to layoff employees who are seemingly responsible for developing new sources of revenue for them? Taking their cues from the IT and software industries, many US drug makers are beginning to either transfer R&D operations to foreign, company-owned research facilities or outsourcing some or all R&D activities to foreign contract research organizations (CROs).
The mere mention of office politics makes me want to cringe. This is probably because I have never been politically motivated nor have I ever taken advantage of a co-worker to advance my career. Those who know me will tell you that I am a tell-it-like-it is kind of guy. And, I simply refuse to play the game to get ahead. That is probably why I am blogger/science writer and not a vice president or CEO of some company. Nevertheless, for those of you who are ambitious and driven, you will need to learn to successfully manage workplace politics because--you don't--you may wind up like me (not that there is anything wrong with that)..jpg)
If you were thinking East Coast cities you would be wrong. Think further west! 
I finally started using Twitter a couple of months ago and I think it is pretty cool. That said, I am still a neophyte and I have yet to master the intricacies and nuances of Twitter speak (why are tweets not called twits?—it was a rhetorical question)..jpg)
Bristol-Myers Squibb (BMS) made a presentation this morning at the Credit Suisse Healthcare Conference that showed the company plans on saving an additional $2.5 billion in “productivity initiatives.” According to its new CFO, the company plans to squeeze the savings out of “headcount and related costs” — which likely means more downsizing and layoffs. Rumors have it that these job cuts will take place by December 1, 2008 just prior to when employee bonuses are traditionally decided..jpg)
I had many discussions with undergraduate students at the ABRCMS in Orlando last week who were interested in pursuing PhD degrees in the biomedical sciences. I felt that I had an ethical and moral responsibility as a former academic and career development professional to tell them that the job market for PhDs is not good and that it is likely to get worse over the next few years. These discussions prompted me to revisit the role and contributions of tenure to the lack of academic jobs in the US today..jpg)
No matter what you may think of Google, you gotta love the brilliance and innovative moxy of the guys who run that company. 
I think that it is safe to say that we are in a recession. Even though unemployment is rising to record levels, there are still jobs to be had. To be successful in tough economic times, job seekers must manage expectations and modify job search tactics. To that end, I came across an i.gif)
Last month, 240,000 American workers lost their jobs. Many of these jobs were lost as a result of corporate lay offs and restructuring—things that are likely to continue as we attempt to navigate a course through these financially troubling times. Unlike being fired, lay offs and job losses that result from restructuring have little to do with individual job performances and everything to do with budget constraints and reductions. That said how should a person who is laid off from a job deal with it on a resume when looking for a new job? I found a 
I just returned from the (2).jpg)
Optimer, a San-Diego, CA-based biopharmaceutical company, reported .jpg){kind=avatar}
The election of Barack Obama last night signals the beginning of the end of the dark ages that have plagued American science for the past 8 years. I hope that one of the first things that Mr. Obama does after he is sworn in as President is to lift the ban on embryonic stem cell research in this country. This unprecedented ban has done more to harm to American science than most lay people realize. Because of it, we are light years behind other countries which have been able to conducted unfettered research in this area..jpg)
The Pharmalot blog reported yesterday that 
According to a recent analysis conducted by .jpg)
Do you ever wonder what the person who you share an office with is making? Or, have you ever wondered what other people think about the CEO of your company? Or, should I consider working at that company? The answers to these questions and more can now be found at a 4-month old website called .jpg)
I am frequently asked by life sciences PhDs whether an MBA would improve their chances of finding a job in industry. And, my response is always “maybe— because it depends. I don’t think that getting a traditional MBA really gives you that much of an edge especially if you are an established PhD looking for career advancement or change. However, if you are a graduate student or postdoc who has already decided that academia is not for you, then getting a certificate or M.S. through an established graduate program in biotechnology (
